CRISPR Therapeutics AG

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: CRISPR Therapeutics AG
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Switzerland
Headquarters city: ZUG
Headquarters country: Switzerland
Fiscal year end: December
Ticker symbol: CRSP
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001674416
EIN: 47-3173478
Wikidata ID: Q104480207

Board of directors

Follow this board

Ali Behbahani · Director Overboarded
Since 2023
Briggs Morrison · Director
Since 2025
Christian Rommel · Director
Since 2024
Douglas A. Treco · Director
Since 2023
Harold Edward Fleming · Director
Since 2023
John Greene · Director
Since 2023
Katherine A. High · Director
Since 2023
Maria Fardis · Director
Since 2023
Samarth Kulkarni · Director · Chief Executive Officer
Since 2023
Sandesh Mahatme · Director
Since 2024
Simeon George · Director
Since 2023

Chief executives

Samarth Kulkarni · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 16 other boards. 16 are in the same sector.

Shared director Other board Same sector

Black Diamond Therapeutics Inc. Same sector
via Ali Behbahani and Samarth Kulkarni
Nkarta Inc. Same sector
via Ali Behbahani and Simeon George
ADARx Pharmaceuticals Inc. Same sector
via Simeon George
Arvinas Inc. Same sector
via Briggs Morrison
CVRx Inc. Same sector
via Ali Behbahani
Design Therapeutics Inc. Same sector
via Simeon George
Incyte Corp. Same sector
via Katherine A. High
Korro Bio Inc. Same sector
via Ali Behbahani
Monte Rosa Therapeutics Inc. Same sector
via Ali Behbahani
Obsidian Therapeutics Inc. Same sector
via Maria Fardis
Oruka Therapeutics Inc. Same sector
via Samarth Kulkarni
Sionna Therapeutics Inc. Same sector
via Harold Edward Fleming
SpyGlass Pharma Inc. Same sector
via Ali Behbahani
Syndax Pharmaceuticals Inc. Same sector
via Briggs Morrison
Upstream Bio Inc. Same sector
via Harold Edward Fleming
Werewolf Therapeutics Inc. Same sector
via Briggs Morrison

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $17,684,424; 28 sales by 6 insiders

Date	Insider	Transaction	Shares	Price	Value
Oct 19, 2026	Samarth Kulkarni Director, Officer (Chief Executive Officer)	Open-market sale	−47,837	$49.78	$2,381,326
Oct 16, 2026	Samarth Kulkarni Director, Officer (Chief Executive Officer)	Option exercise	+100,000	—	—
Oct 14, 2026	Simeon George Director	Option exercise	+30,000	$14.00	$420,000
Oct 14, 2026	Simeon George Director	Open-market sale	−14,514	$49.63	$720,373
Oct 6, 2026	KASINGER JAMES R. Officer (General Counsel and Secretary)	Option exercise	+1,990	$13.62	$27,104
Oct 6, 2026	KASINGER JAMES R. Officer (General Counsel and Secretary)	Open-market sale	−1,990	$60.04	$119,481
Sep 22, 2026	KASINGER JAMES R. Officer (General Counsel and Secretary)	Option exercise	+10,400	$13.62	$141,648
Sep 22, 2026	KASINGER JAMES R. Officer (General Counsel and Secretary)	Open-market sale	−10,400	$60.24	$626,496
Sep 17, 2026	Ali Behbahani Director	Option exercise	+30,000	$14.00	$420,000
Sep 17, 2026	Ali Behbahani Director	Open-market sale	−13,679	$57.09	$780,934
Aug 7, 2026	Prasad Raju Officer (Chief Financial Officer)	Gift	−750	—	—
May 29, 2026	Patel Naimish Officer (Chief Medical Officer)	Open-market sale	−3,786	$55.62	$210,577
May 28, 2026	Patel Naimish Officer (Chief Medical Officer)	Option exercise	+10,000	—	—
Mar 23, 2026	KASINGER JAMES R. Officer (General Counsel and Secretary)	Open-market sale	−3,182	$46.78	$148,854
Mar 23, 2026	Samarth Kulkarni Director, Officer (Chief Executive Officer)	Open-market sale	−10,020	$46.78	$468,736

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

AC Immune SA Nasdaq: ACIU · 1015 Lausanne, Switzerland Organization ADC Therapeutics SA NYSE: ADCT · Epalinges, Switzerland Organization Addex Therapeutics Ltd Nasdaq: ADXN · Geneva, Switzerland Organization Alcon Inc. NYSE: ALC · Fort Worth, Switzerland Organization

Questions about CRISPR Therapeutics AG

Who is the CEO of CRISPR Therapeutics AG?

Samarth Kulkarni is CRISPR Therapeutics AG's Chief Executive Officer.

How many directors are on CRISPR Therapeutics AG's board?

CRISPR Therapeutics AG's board has 11 directors: Ali Behbahani, Briggs Morrison, Christian Rommel, Douglas A. Treco, Harold Edward Fleming, John Greene, Katherine A. High, Maria Fardis, Samarth Kulkarni, Sandesh Mahatme and 1 other.

Are CRISPR Therapeutics AG insiders buying or selling shares?

Over the last 12 months, CRISPR Therapeutics AG insiders made no open-market purchases and sold $17.7 million of shares in 28 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is CRISPR Therapeutics AG connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="crispr-therapeutics-ag"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.